Idaho Society of Cancer Oncology

Welcome

The Idaho Society of Clinical Oncology (ISCO) represents Idaho physicians and related health care professionals who care for cancer patients. The Society is a non-profit corporation devoted to the improvement of hematologic and oncologic care of patients.

The Benefits of Membership

Membership in the Society is open to all professionals whose primary endeavor is the delivery of oncology care,  including physicians, nurse practitioners, physician assistants and pharmacists. Membership is restricted to those individuals primarily delivering care in the State of Idaho and is FREE to qualified professionals

 

Join Today

 

ASCO has announced fifteen distinguished members selected by the Nominating Committee as candidates for open leadership positions within the Society. From November 1 to December 3, 2018, eligible ASCO members are encouraged to vote to choose new leaders and on proposed amendments to the ASCO Bylaws. To learn more about the candidates, click here and log into your ASCO account.


 

Webinar: 2019 Medicare Reimbursement -- Final Rules Update

The Centers for Medicare and Medicaid Services recently published the final rules for 2019 Medicare reimbursement. ASCO is hosting a webinar to outline the rules and explain changes on December 5, 2018 from 4:00 – 5:00 PM Eastern. Please register now and encourage your members to do the same.

Upcoming Events

ISCO Fall Meeting
Dates: October 5-6, 2018
Location: Boise Centre
850 W. Front St. Boise, ID 83702

Click here for the Presentations*

*  presentations are in the Members Area.  You will need to log in to access.

 

Click here for presentations

CMS Releases Physician Fee Schedule Final Rule
The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.